(GSA) SSA/EA/Rig eval (Pharm S&S)
Past New Requirement Updated
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Solicitation expected
- Not on record
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- Not on record
- Points of contact
-
- Joanna Elmi zft6@cdc.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Centers for Disease Control and Prevention (CDC) is forecasting a new contract opportunity focused on implementing an enhanced pharmacist intervention strategy to improve hypertension control and expand healthcare access. The contract, estimated for award on August 1, 2025, will utilize advanced evaluation methods to develop and deploy pharmacist-led healthcare interventions. This procurement appears to be part of the CDC's National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) initiative to address hypertension management.
While specific award values are not currently disclosed, the contract involves a comprehensive approach to healthcare intervention design and implementation. The primary point of contact is Joanna Elmi, a staff member at NCCDPHP, who can be reached at zft6@cdc.gov for potential inquiries. The solicitation is currently set without any specific small business set-aside provisions, suggesting it may be open to a wide range of qualified healthcare and research organizations with expertise in chronic disease prevention and pharmacist-led healthcare strategies.
Forecast text
Utilizing Enhanced Evaluation Methods to Implement an Effective Pharmacist Intervention to Improve Hypertension Control and Expand Access to Healthcare
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast